st 1435 has been researched along with Body Weight in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carreira, CM; Coutinho, EM; da Silva, AR; Sivin, I | 1 |
| Athayde, C; Barbosa, I; Coutinho, EM; Dantas, C; Hirsch, C | 1 |
| Gordon, K; Heikinheimo, O; Lähteenmäki, P; Moo-Young, A; Ranta, S | 1 |
| Laurikka-Routti, M | 1 |
1 trial(s) available for st 1435 and Body Weight
| Article | Year |
|---|---|
Use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women.
Topics: Adult; Amenorrhea; Body Constitution; Body Weight; Breast Feeding; Child Development; Contraceptive Agents, Female; Drug Implants; Female; Humans; Infant; Intrauterine Devices, Copper; Menstruation; Milk, Human; Norprogesterones; Postpartum Period | 1999 |
3 other study(ies) available for st 1435 and Body Weight
| Article | Year |
|---|---|
Long-term contraception with a single implant of the progestin ST-1435.
Topics: Amenorrhea; Blood Pressure; Body Weight; Drug Implants; Female; Humans; Norpregnenes; Norprogesterones; Pregnancy; Progesterone Congeners; Time Factors | 1981 |
Parenteral administration of progestin Nestorone to lactating cynomolgus monkeys: an ideal hormonal contraceptive at lactation?
Topics: Animals; Animals, Newborn; Body Weight; Contraceptive Agents, Female; Female; Haplorhini; Lactation; Milk; Norprogesterones | 1999 |
Serum lipids, blood pressure, body weight, and serum chemistry in women using subcutaneous contraceptive implants releasing the progestin ST 1435.
Topics: Adult; Blood Pressure; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Drug Implants; Female; Humans; Lipids; Norprogesterones; Time Factors; Triglycerides | 1992 |